The genomic revolution is driving medicine development into new and innovative areas. Most notably, drug production continues to grow. In addition to the chemically based treatments we’ve always known, we now see a proliferation of highly effective biologic therapies.
Creating these new biological drugs is done through bio-production, a technique that depends on the production of vast numbers of new cells – sometimes up to a trillion or more. This, in turn, requires highly specialised vessels, surfaces and media for developing cells under precise conditions.
Ever since we introduced PYREX® glass in 1915, Corning has been a trusted supplier to the drug discovery business. Our labware helped to enable the early production and distribution of such world-changing medicines as penicillin and the polio vaccine. And as pharmaceutical and biotechnology companies have changed their research focus from high volume, low-margin medicines to rare diseases and specialised medicine, we have built a position of global leadership.
Our customers use our innovative products as they develop new treatments for conditions like arthritis and cancer, as well as vaccines for global health threats like the Ebola virus.
